DTL
KYMR icon

Dynamic Technology Lab’s Kymera Therapeutics KYMR Stock Holding History

Dynamic Technology Lab’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,471
Closed -$462K – 1192
2024
Q2 		$462K Buy
+15,471
New +$536K 0.05% 539
2023
Q4 		– Sell
-11,359
Closed -$158K – 1234
2023
Q3 		$158K Sell
11,359
-9,711
-46% -$195K 0.02% 822
2023
Q2 		$484K Buy
+21,070
New +$604K 0.06% 516
2022
Q4 		– Sell
-25,480
Closed -$555K – 1322
2022
Q3 		$555K Buy
+25,480
New +$672K 0.05% 591

Other funds holding KYMR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Dynamic Technology Lab's KYMR Position: Q3 2024 in Review

Dynamic Technology Lab sold out of Kymera Therapeutics (KYMR) in Q3 2024, closing a stake of 15,471 shares — an estimated $462K sold.

Dynamic Technology Lab first reported a position in KYMR in Q3 2022 and held it in 4 quarters. The position peaked at $555K in Q3 2022. 176 funds tracked by Wall St. Rank hold KYMR as of Q3 2024.

  • Dynamic Technology Lab reported no remaining Kymera Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 15,471 Kymera Therapeutics shares in Q3 2024, an estimated $462K.
  • Dynamic Technology Lab first reported a position in Kymera Therapeutics in Q3 2022 and held it in 4 quarters.
  • Dynamic Technology Lab's Kymera Therapeutics position peaked at $555K in Q3 2022.
  • 176 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2024.

Based on Dynamic Technology Lab's 13F filing for Q3 2024, filed 13 Nov 2024.